EUVIMEDEUVIMED entdecken
Crossref

Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV ‐1 vaccine formulations

Alireza Milani, Elahe Akbari, Parisa Moradi Pordanjani, Fateme Jamshidi, Shahrzad Ghayoumi, Seyed Amir Sadeghi, Azam Bolhassani iD

HIV Medicine · 2024

DOI: 10.1111/hiv.13576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIV Medicine, 2024. Verfasst von Alireza Milani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heat shock proteins (HSPs) as an adjuvant induce antigen‐specific immunity through facilitating antigen presentation and stimulating T cells. In this study, the immunostimulatory properties of two major fragments of Hsp70 (N‐Hsp70 (aa 1–387) with ATPase property and C‐Hsp70 (aa 508–641) with peptide‐binding capacity) and the full length of Hsp27 as vaccine adjuvants were evaluated to boost HIV‐1 Nef antigen‐specific immunity in both in vitro and in vivo experiments. Method s At first, the nanoparticles harbouring DNA fusion constructs (i.e. N‐Hsp70‐Nef, C‐Hsp70‐Nef and Hsp27‐Nef) complexed with HIV Rev (34–50) cell‐penetrating peptide were generated to deliver DNA into the cells. Then, the recombinant Nef, Hsp27‐Nef, N‐Hsp70‐Nef and C‐Hsp70‐Nef proteins were generated in E.coli expression system. Next, the immunostimulatory properties of these fusion constructs were evaluated in both in vitro and in vivo studies. Finally, the secretion of main cytokines from single‐cycle replicable (SCR) HIV‐1 virion‐exposed splenocytes was investigated.

Results

Our data showed that the stable and non‐toxic DNA/Rev nanoparticles could successfully deliver the genes of interest into the cells. Moreover, higher secretion of antibodies and cytokines was detected in mice receiving the Hsp‐Nef constructs than in mice receiving Nef antigen. The C‐Hsp70 was also superior for inducing Nef‐specific Th1 and CTL immunity compared with N‐Hsp70 and Hsp27. The T‐cell activity was maintained in the SCR‐exposed splenocytes, especially the splenocytes of mice receiving the C‐Hsp70‐Nef regimen.

Conclusion

Altogether, these findings demonstrate the significance of Hsps as enhancers of antigen‐specific immunity. Notably, the C‐Hsp70 region showed better adjuvant properties for inducing cellular immunity in the improvement of HIV‐1 therapeutic vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsVaccinesMiceAnimalsHumansHSP70 Heat-Shock ProteinsHeat-Shock ProteinsAdjuvants, ImmunologicCytokinesDNA

Stichwörter der Autor:innen

HIV-1 NefHsp27Hsp70SCRcell-penetrating peptideheat shock protein

Substanzen

HSP70 Heat-Shock ProteinsHeat-Shock ProteinsAdjuvants, ImmunologicCytokinesVaccinesDNA

Autor:innen und Institutionen

  • Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
  • Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.

ORCID-Profile: Azam Bolhassani

Zitieren

APA

Milani, A., Akbari, E., Pordanjani, P. M., Jamshidi, F., Ghayoumi, S., Sadeghi, S. A., & Bolhassani, A. (2024). Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV ‐1 vaccine formulations. HIV Medicine. https://doi.org/10.1111/hiv.13576

Vancouver

Milani A, Akbari E, Pordanjani PM, Jamshidi F, Ghayoumi S, Sadeghi SA, et al. Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV ‐1 vaccine formulations. HIV Medicine. 2024. doi:10.1111/hiv.13576

BibTeX
@article{Milani2024,
  author = {Milani, Alireza and Akbari, Elahe and Pordanjani, Parisa Moradi and Jamshidi, Fateme and Ghayoumi, Shahrzad and Sadeghi, Seyed Amir and Bolhassani, Azam},
  title = {Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV ‐1 vaccine formulations},
  journal = {HIV Medicine},
  year = {2024},
  doi = {10.1111/hiv.13576}
}
Kostenlos starten →